- Home
- DVAX
DVAX
Dynavax Technologies Corporation
as 05-15-2025 4:00pm EST
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | N/A | IPO Year: | 2004 |
| Target Price: | $26.25 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.74 - $14.63 | Next Earning Date: | 05-06-2025 |
| Revenue: | $294,620,000 | Revenue Growth: | 24.76% |
| Revenue Growth (this year): | 21.18% | Revenue Growth (next year): | 16.57% |
Stock Insider Trading Activity of Dynavax Technologies Corporation (DVAX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Novack David F | DVAX | President & COO | Mar 24 '25 | Sell | $14.00 | 10,000 | $140,000.00 | 8,078 | |
| Novack David F | DVAX | President & COO | Mar 18 '25 | Sell | $13.58 | 14,020 | $190,391.60 | 8,078 | |
| Novack David F | DVAX | President & COO | Mar 7 '25 | Sell | $14.39 | 32,764 | $471,473.96 | 8,078 |
Latest Dynavax Technologies Corporation News
DVAX Breaking Stock News: Dive into DVAX Ticker-Specific Updates for Smart Investing
Argus Research
2 days ago
DVAX: Lowering target price to $10.00
PR Newswire
3 days ago
Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value
PR Newswire
6 days ago
/C O R R E C T I O N -- Dynavax Technologies/
Zacks
7 days ago
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
Simply Wall St.
7 days ago
Dynavax Technologies First Quarter 2025 Earnings: EPS Misses Expectations
GuruFocus.com
9 days ago
Dynavax Technologies Corp (DVAX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...
Argus Research
9 days ago
DVAX: Lowering target price to $11.00
Zacks
9 days ago
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
Compare DVAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DVAX Dynavax Technologies Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.